> top > docs > PMC:7293470 > spans > 2052-2346 > annotations

PMC:7293470 / 2052-2346 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T72 38-53 CHEBI:52217;CHEBI:52217 denotes pharmacological
T73 54-59 CHEBI:23888;CHEBI:23888 denotes drugs
T74 125-134 UBERON:0002048 denotes pulmonary
T75 202-208 UBERON:0001005 denotes airway
T76 209-222 UBERON:0001135 denotes smooth muscle
T77 240-250 CHEBI:7034;CHEBI:7034 denotes muscarinic
T78 251-271 CHEBI:48561;CHEBI:48561 denotes receptor antagonists
T49829 38-53 CHEBI:52217;CHEBI:52217 denotes pharmacological
T6948 54-59 CHEBI:23888;CHEBI:23888 denotes drugs
T52070 125-134 UBERON:0002048 denotes pulmonary
T37965 202-208 UBERON:0001005 denotes airway
T82075 209-222 UBERON:0001135 denotes smooth muscle
T68520 240-250 CHEBI:7034;CHEBI:7034 denotes muscarinic
T83831 251-271 CHEBI:48561;CHEBI:48561 denotes receptor antagonists

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T28 216-222 Body_part denotes muscle http://purl.org/sig/ont/fma/fma32558

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T19 91-97 Disease denotes asthma http://purl.obolibrary.org/obo/MONDO_0004979
T20 105-142 Disease denotes chronic obstructive pulmonary disease http://purl.obolibrary.org/obo/MONDO_0005002
T21 125-142 Disease denotes pulmonary disease http://purl.obolibrary.org/obo/MONDO_0005275
T22 144-148 Disease denotes COPD http://purl.obolibrary.org/obo/MONDO_0005002

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T41 202-208 http://purl.obolibrary.org/obo/UBERON_0001005 denotes airway
T42 216-222 http://purl.obolibrary.org/obo/UBERON_0001630 denotes muscle
T43 216-222 http://purl.obolibrary.org/obo/UBERON_0005090 denotes muscle
T44 216-222 http://www.ebi.ac.uk/efo/EFO_0000801 denotes muscle
T45 216-222 http://www.ebi.ac.uk/efo/EFO_0001949 denotes muscle

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T25 54-59 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T26 184-192 Chemical denotes agonists http://purl.obolibrary.org/obo/CHEBI_48705
T27 260-271 Chemical denotes antagonists http://purl.obolibrary.org/obo/CHEBI_48706
T28 281-283 Chemical denotes M3 http://purl.obolibrary.org/obo/CHEBI_51083|http://purl.obolibrary.org/obo/CHEBI_53453

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T5 91-97 Phenotype denotes asthma http://purl.obolibrary.org/obo/HP_0002099
T6 105-142 Phenotype denotes chronic obstructive pulmonary disease http://purl.obolibrary.org/obo/HP_0006510
T7 144-148 Phenotype denotes COPD http://purl.obolibrary.org/obo/HP_0006510

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T11 0-294 Sentence denotes As relevant examples reviewed in [5], pharmacological drugs for treatment of patients with asthma and/or chronic obstructive pulmonary disease (COPD) were developed to include both β2-agonists to relax airway smooth muscle constriction and muscarinic receptor antagonists to block M3 receptors.

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
115 181-183 Gene denotes β2 Gene:170589
130 77-85 Species denotes patients Tax:9606
136 91-97 Disease denotes asthma MESH:D001249
137 105-142 Disease denotes chronic obstructive pulmonary disease MESH:D029424
138 144-148 Disease denotes COPD MESH:D029424